Clinical Trials

Accrual Status
Limit to SWOG Trials

1033 Results

Status Trial Number Title Sort descending Activated Closed Accrual Phase Published
Closed SWOG-8326/27 Evaluation of Combination Chemotherapy Using High Dose Ara-C in Adult Acute Leukemia and Chronic Granulocytic Leukemia in Blastic Crisis 4/26/1985 12/15/1992 99% Published
Closed SWOG-8219 Evaluation of Combined or Sequential Chemo-Endocrine Therapy in the Treatment of Advanced Adenocarcinoma of the Prostate 8/11/1984 10/1/1986 Published
Closed SWOG-8935 Evaluation of Continuous Infusion Interleukin-2 (IL-2) in Patients with Squamous Cell Carcinoma of the Head and Neck, Phase II 11/15/1990 6/15/1992 14%
Closed SWOG-8235 Evaluation of Continuous Infusion Vinblastine in Gastric Carcinoma. 10/18/1983 2/1/1987 Published
Closed SWOG-8237 Evaluation of Continuous Infusion Vinblastine Sulfate in Pancreatic Adenocarcinoma 5/27/1983 3/22/1985 Published
Closed SWOG-8030 Evaluation of DHAD in Advanced Squamous Cell Carcinoma of the Head and Neck 10/20/1980 1/31/1983 Published
Closed SWOG-8028 Evaluation of DHAD in Gynecologic Cancers 10/20/1980 10/3/1984 Published
Closed SWOG-8043 Evaluation of DHAD in Pancreatic Adenocarcinoma 1/28/1981 8/17/1984 Published
Closed SWOG-8031 Evaluation of DHAD in Refractory Multiple Myeloma 11/21/1980 3/30/1983 Published
Closed SWOG-8004 Evaluation of DHAD in Soft Tissue and Bone Sarcomas 7/3/1980 7/28/1981 Published
Closed SWOG-8371 Evaluation of Diamine (1,1-Cyclobutane-Dicarboxylato-(2)-0,0')-CSP-4-2)Platinum (CBDCA-NSC-241240) and Cis-Dichloro-Trans-Dihydroxy-Bis-(Isoprpylamine)-Platinum IV (CHIP-NSC-256927) for Patients with… 12/22/1983 9/27/1985 Published
Closed SWOG-8754 Evaluation of Didemnin B in Disseminated Malignant Melanoma 1/15/1989 5/1/1990 Published
Closed SWOG-8728 Evaluation of Didemnin B in Metastatic Adenocarcinoma of the Kidney 1/1/1988 2/1/1989 Published
Closed SWOG-8640 Evaluation of Didemnin-B or Trimetrexate in the Treatment of Metastatic or Recurrent Squamous Carcinoma of the Uterine Cervix 10/1/1987 7/15/1990 88% Published
Closed SWOG-8032 Evaluation of Dihydroxyanthracenedione (DHAD) in Acute Leukemia 10/22/1980 9/10/1982 Published
Closed SWOG-8010 Evaluation of Dihydroxyanthracenedione (DHAD) in Advanced Prostate Cancer 7/2/1980 12/28/1981
Closed SWOG-8011 Evaluation of Dihydroxyanthracenedione (DHAD) in Patients with Advanced Renal Cell Carcinoma 7/2/1980 4/14/1981
Closed SWOG-8008 Evaluation of Dihydroxyanthracenedione (DHAD) in Refractory Breast Cancer 7/2/1980 9/10/1982
Closed SWOG-8005 Evaluation of Dihydroxyanthracenedione (DHAD) in Refractory Malignant Lymphomas 7/2/1980 5/10/1982
Closed SWOG-8009 Evaluation of Diydroxythracenedione (DHAD) in Patients with Refractory Small Cell Lung Cancer 7/3/1980 5/11/1982 Published
Scroll Table